|
![]() |
|
→ AHR Home
Click to Login
Hide the Login Box
→ Click here for subscription options
→ Email AHHA to purchase a pdf of this issue
|
Contents May 2009 |
||
From the Editor |
The economic crisis, the Pharmaceutical Benefits Scheme, and the dilemmas of medicines policy
|
PBS Reform |
PBS reform — a missed opportunity?
|
The PBS in a globalised world: free trade and
reference pricing
|
Medicines Pricing |
Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme
|
High prices for generics in Australia —
more competition might help
|
Copayments — Evidence and Critiques |
The impact of copayments and safety nets on
PBS expenditure
|
Australia’s pharmaceutical cost sharing policy:
reducing waste or affordability?
|
PBS copayments and safety nets
|
Innovation and Professional Realignments |
Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan
|
Policy challenges of nanomedicine for Australia’s PBS
|
Doctor and pharmacist — back to the apothecary!
|
Complementary Medicines — Enhancing Consumer Protection |
A review of proposals to reform the regulation of complementary medicines
|
Complementary medicines regulatory reform
|
Book Reviews |
Medicines policy and drug company investments:
the Irish experience
|
Interpreting the global bio-economy
|
Models of Care |
Editorial
|
Becoming Australian? Two different approaches to health care reform in the United States
|
Other Topics |
GP access to MRI: the Australian reality
|
Working together: collaboration between midwives and doctors in public hospitals
|
Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study
|
The AusPSIs: the Australian version of the Agency of Healthcare Research and Quality patient safety indicators
|
|
| Home | Archives | Terms of use | Contact | Topics |
<URL:http://www.aushealthreview.com.au/>
© 2009 Australian Health Review.